Literature DB >> 22327341

Neurogenic and myogenic contributions to hereditary motor neuron disease.

Katherine V Bricceno1, Kenneth H Fischbeck, Barrington G Burnett.   

Abstract

Spinal muscular atrophy and spinal and bulbar muscular atrophy are characterized by lower motor neuron loss and muscle atrophy. Although it is accepted that motor neuron loss is a primary event in disease pathogenesis, inherent defects in muscle may also contribute to the disease progression and severity. In this review, we discuss the relative contributions of primary pathological processes in the motor axons, neuromuscular junctions and muscle to disease manifestations. Characterizing these contributions helps us to better understand the disease mechanisms and to better target therapeutic intervention.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22327341      PMCID: PMC3369264          DOI: 10.1159/000335311

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  110 in total

1.  Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.

Authors:  Elisabet Dachs; Marta Hereu; Lídia Piedrafita; Anna Casanovas; Jordi Calderó; Josep E Esquerda
Journal:  J Neuropathol Exp Neurol       Date:  2011-06       Impact factor: 3.685

2.  Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis.

Authors:  Tessa L Carrel; Michelle L McWhorter; Eileen Workman; Honglai Zhang; Elizabeth C Wolstencroft; Christian Lorson; Gary J Bassell; Arthur H M Burghes; Christine E Beattie
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

3.  Human profilin. Molecular cloning, sequence comparison, and chromosomal analysis.

Authors:  D J Kwiatkowski; G A Bruns
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

4.  Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.

Authors:  T Shimohata; T Nakajima; M Yamada; C Uchida; O Onodera; S Naruse; T Kimura; R Koide; K Nozaki; Y Sano; H Ishiguro; K Sakoe; T Ooshima; A Sato; T Ikeuchi; M Oyake; T Sato; Y Aoyagi; I Hozumi; T Nagatsu; Y Takiyama; M Nishizawa; J Goto; I Kanazawa; I Davidson; N Tanese; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons.

Authors:  Claudia Fallini; Honglai Zhang; Yuehang Su; Vincenzo Silani; Robert H Singer; Wilfried Rossoll; Gary J Bassell
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

6.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

Review 7.  The SMN complex, an assemblyosome of ribonucleoproteins.

Authors:  Sergey Paushkin; Amélie K Gubitz; Séverine Massenet; Gideon Dreyfuss
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

8.  Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.

Authors:  Amy M Avila; Barrington G Burnett; Addis A Taye; Francesca Gabanella; Melanie A Knight; Parvana Hartenstein; Ziga Cizman; Nicholas A Di Prospero; Livio Pellizzoni; Kenneth H Fischbeck; Charlotte J Sumner
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

9.  Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation.

Authors:  Gabriella Dobrowolny; Michela Aucello; Antonio Musarò
Journal:  Skelet Muscle       Date:  2011-01-24       Impact factor: 4.912

10.  Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

Authors:  Gianni Sorarù; Carla D'Ascenzo; Alberto Polo; Arianna Palmieri; Linda Baggio; Lodovica Vergani; Cinzia Gellera; Giuseppe Moretto; Elena Pegoraro; Corrado Angelini
Journal:  J Neurol Sci       Date:  2007-09-12       Impact factor: 3.181

View more
  3 in total

1.  Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.

Authors:  Constanza J Cortes; Shuo-Chien Ling; Ling T Guo; Gene Hung; Taiji Tsunemi; Linda Ly; Seiya Tokunaga; Edith Lopez; Bryce L Sopher; C Frank Bennett; G Diane Shelton; Don W Cleveland; Albert R La Spada
Journal:  Neuron       Date:  2014-04-16       Impact factor: 17.173

Review 2.  More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases.

Authors:  Justin G Boyer; Andrew Ferrier; Rashmi Kothary
Journal:  Front Physiol       Date:  2013-12-18       Impact factor: 4.566

3.  Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy.

Authors:  Carlo Rinaldi; Laura C Bott; Ke-lian Chen; George G Harmison; Masahisa Katsuno; Gen Sobue; Maria Pennuto; Kenneth H Fischbeck
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.